If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

DexCom's key Q3 earnings factors include Stelo sales, updates on sales channels, and potential share buybacks. See why I ...

A 10-year-old boy from New Town has been living life to the fullest despite his recent diagnosis of Type 1 diabetes.

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Valeo Financial Advisors LLC raised its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 31.8% in the third ...

Ultimately, the right stocks for your portfolio will depend on numerous factors, including your risk tolerance level, ...

Sanctuary Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the second ...

Labaton Keller Sucharow LLP (“Labaton”) announces that, on October 8, 2024, it filed a securities class action lawsuit (the ...

Medical device maker DexCom (DXCM) operates in a highly competitive market for continuous glucose monitoring (CGM) systems, ...

PITTSBURGH — A device used by diabetics is now over-the-counter, making it easier for people to get. The device could be so ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...